A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer resistance to enzalutamide, a frequently used drug. The article is published in ...

Prostate cancer hijacks the normal prostate's growth regulation program to release the brakes and grow freely, according to Weill Cornell Medicine researchers. The discovery, published Dec. 13 in ...

A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a study conducted by researchers at Umeå University together with ...

Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism ...

A fully human therapeutic antibody has been shown to stop prostate tumor growth and metastasis via a novel mechanisms of ...

Stay connected via Google News Scientists at Umeå University in Sweden and partner institutions have developed an ...

Researchers have developed a fully human antibody that suppressed tumor growth and metastatic spread in preclinical models of aggressive prostate cancer. Credit: Shutterstock A fully human antibody ...

According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime. In addition, about 1 in 44 men will die from the disease, ...

Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men worldwide. However, the mechanisms controlling the early stages of prostate cancer ...

President Joe Biden recently gave an update on his treatment for metastatic prostate cancer. A urologist explains ways to ...